Close Menu
Home » Illumina

Illumina

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.

Illumina Company Profile 

 

President & CEO: Francis deSouza

CEO photo:

illumina CEO Francis deSouza photo

Website: www.illumina.com

Ticker symbol: ILMN

Headquarters: San Diego, CA

Illumina employees: 5,500+ globally

Revenues: $2.4 Billion USD in 2016

Founded: 1998

Founders: Larry Bock, Anthony Czarnik, David Walt, Mark Chee, John Stuelpnagel

 

Illumina News 

Jun 26, 2019

Illumina, AnchorDx to Develop Genomic Cancer Tests for Chinese Market

AnchorDx, based in Guangzhou in southern China, will use Illumina's MiSeqDx sequencer to develop IVD cancer test kits and data analysis software.

Jun 19, 2019

Time Off and a Connection

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

Jun 18, 2019

UK Request Pushes Illumina's Timeline for Completion of PacBio Acquisition to Q4

The UK Competition and Markets Authority has announced concerns that the $1.2 billion merger will reduce competition for Illumina and could scrutinize it further.

Jun 17, 2019

Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics

A UK court determined that Ariosa's licensee infringed upon at least one claim of Illumina's European patent 1 524 321 and upheld the patent's validity.

Jun 17, 2019

University of Glasgow Team to Integrate Genomics Into New Cancer Clinical Trials Network

Premium

Patients who enroll will have their samples tested as part of routine diagnostic care, making it easier for them to take part in clinical trials without additional testing.

Jun 14, 2019

Genes for Good Project Seeks Funding, Collaborations to Advance Use of Genetic Database

Premium

The Genes for Good Project has engaged 80,000 Facebook users via its online application and genotyped 27,000 people to date.

Jun 07, 2019

NatGeo Discontinues Genographic Ancestry Kit Sales, Will Shutter Service by End of 2020

Premium

NatGeo will continue to conduct research using its database, which includes data on roughly a million individuals.

May 29, 2019

MGI's US Subsidiary Files Patent Infringement Suit Against Illumina

The complaint, filed yesterday, alleges that Illumina's two-channel sequencing systems infringe Complete Genomics' US Patent No. 9,222,132.

May 28, 2019

MyHeritage Moves Into Health with New Genetic Testing Offering, Underscoring Industry Trend

Premium

The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.

May 24, 2019

Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays

Premium

Investigators concluded that the spiked samples from SeraCare were a robust tool for inter-lab comparisons and discussed some areas of discordance seen in the study.

Pages

The Scan

New Privacy Coalition

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

Less Sweat, More Diverse Microbiome

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

Oh, This Code

The Wall Street Journal examines billing codes used by uBiome.

PNAS Studies Look at Lung Cancer LncRNA, Hi-C Clustering, and More

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.

What's Popular?

In Illumina

  1. Illumina, AnchorDx to Develop Genomic Cancer Tests for Chinese Market

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.